On April 28, 2026 the Jeffrey Modell Foundation (JMF) will host Luigi D. Notarangelo, M.D., the Chief of the Immune Deficiency Genetics Section at the National Institute of Allergy and Infectious ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with primary immunodeficiencies demonstrated ...

Immunodeficiency diseases have traditionally been defined as defects in the development and function of T and B cells, the primary effector cells of specific cellular and humoral immunity respectively ...

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.

Please provide your email address to receive an email when new articles are posted on . Ocular manifestations appeared common among patients with primary immunodeficiency diseases, suggesting a need ...

FRISCO, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex ...

Over one fourth of patients with common variable immunodeficiency have allergic diseases, with immunoglobulin E levels linked ...

Scientists have long queried the causes of immune disorders in only one of two identical twins with identical genes. New research from the Wellcome Sanger Institute, the Josep Carreras Leukaemia ...

Living with primary immunodeficiency (PI) means getting sick more often than others, taking a long time to recover from an illness, and experiencing recurring infections. The uncertainty and ...

A new immunodeficiency disease caused by a novel genetic mutation has been identified by researchers, providing unique insights into cell biology. A new immunodeficiency disease caused by a novel ...

This grant builds upon Tessera’s existing investment from the Gates Foundation to develop a curative in vivo genetic ...